Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade) [Seeking Alpha]
Ardelyx, Inc. (ARDX)
Last ardelyx, inc. earnings: 3/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ardelyx.com/investor-relations
Company Research
Source: Seeking Alpha
Ardelyx raised U.S. revenue forecasts for Ibsrela in IBS-C to $1 billion, targeting about 10% of the market. Q1 earnings showed strong revenue growth but were offset by doubled SG&A expenses, maintaining a net loss. Downgrading ARDX stock to "Hold" due to the current valuation fully reflecting tenapanor's potential, despite financial and operational risks. Introduction Since my October review Ardelyx, Inc. NASDAQ: ARDX ) stock has increased by 120%. Tenapanor, their lead asset, which is making headway in the IBS-C market and recently received approval to treat hyperphosphatemia in Recommended For You Recommended For You
Show less
Read more
Impact Snapshot
Event Time:
ARDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARDX alerts
High impacting Ardelyx, Inc. news events
Weekly update
A roundup of the hottest topics
ARDX
News
- Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor) [Yahoo! Finance]Yahoo! Finance
- Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)GlobeNewswire
- Ardelyx, Inc. Reports Employment Inducement GrantsGlobeNewswire
- Ardelyx, Inc. (NASDAQ: ARDX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Ardelyx: Strong Execution, Fairly Valued [Seeking Alpha]Seeking Alpha
ARDX
Earnings
- 5/2/24 - Beat
ARDX
Sec Filings
- 5/15/24 - Form 4
- 5/14/24 - Form 144
- 5/9/24 - Form 4
- ARDX's page on the SEC website